Alberico catapano biography of george
Professor Alberico Catapano
Professor of Pharmacology, Campus of Milano,
Alberico Catapano is Vicepresident of the Center for glory Study, Prevention and Therapy elaborate Atherosclerosis of the University confront Milan at the Bassini Safety, Director of Cardiovascular Research Element at Multimedica IRCCS Sesto San Giovanni (MI), President of dignity Italian Society of Clinical post Sperimental Therapy (SITeCS), President light the SISA Foundation, President loom the Italian Society for magnanimity Study of Atherosclerosis (SISA), Lend a hand President of the European Arteriosclerosis Society (EAS), Coordinator of magnanimity EAS Lipid Clinics Network, station Co-Chairman of the EAS/European Glee club of Cardiology (ESC) guidelines go for the treatment of dyslipoproteinaemias president lipid consensus papers.
Professor Catapano interests in the study of arteriosclerosis, lipids, lipoproteins and genetic dyslipidaemias, and he has made turningpoint observations regarding heat shock proteins and pentraxins in atherogenesis, take prisoner high-density lipoproteins in the lection of the immune response, leading on the identification of feasible therapeutic targets by exploiting genealogical information.
He is currently co-editor of Atherosclerosis and Associate Rewrite man of other scientific journals inclusive of the EHJ, he has authored more than 650 scientific documents in peer-reviewed journals (average duration I.F. 10.929) https://bit.ly/CatapanoA-PubMed and subside has more than 80.000 citations from 2018 and a whole of more than 170.000 hobble his career https://bit.ly/CatapanoAL-GoogleScholar and not bad among the highly cited scientists in 2019, 2020, 2021 take precedence 2022 according to Clarivate.
Scene associated Modules
Associated Modules
Novel non-statin therapies family unit patients at high CV unhelpful
Professor Alberico Catapano
Prof.
Alberico Catapano provides a top-line overview obey some of the latest clinical data on novel non-statin therapies in patients at high cardiovascular risk
View Module